China Pharma Holdings Inc (CPHI) Annual Balance Sheets

Annual · GAAP · USD millions
Access CPHI quarterly Balance Sheets →
Tracking balance sheet results across China Pharma Holdings Inc to Dec 31 2021 helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.35
Other Restricted Assets, Current0.00
Cash & Short-term Investments0.00
Accounts receivable0.24
Other Receivables, Net, Current0.05
Inventories1.62
Other Current Assets0.00
Prepaid Expense, Current AS0.08
Total Current Assets2.35
Equipment/Property/Plant Net37.88
Intangible Assets24.08
Tax Assets, Noncurrent21.20
Other Assets, Noncurrent0.00
Total Assets31.00
Liabilities
Accounts Payable2.56
Accrued Liabilities, Current AC0.35
Short-term Debt DE11.44
Other Liabilities, Current0.00
Taxes Payable, Current, Total0.35
Total Current Liabilities7.40
Long-term debt0.00
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net, Noncurrent LI0.75
Other liabilities, Noncurrent0.00
Bankers Acceptance Notes Payable0.04
Total Liabilities8.26
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock58.54
Retained Earnings / Accumulated Deficit-47.21
Accumulated Other Comprehensive Income11.58
Other Equity11.58
Common Stockholder's Equity22.74
Total Stockholder's Equity22.74
Liabilities & Stockholder's Equity31.00
4 historic quarters locked

Sign in to unlock the full China Pharma Holdings Inc balance sheet history.

About China Pharma Holdings Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001213900-26-038521

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License